본문으로 건너뛰기
← 뒤로

Chronic obstructive pulmonary disease as a double-edged sword-reshaping NSCLC immunotherapy paradigms.

2/5 보강
Med (New York, N.Y.) 📖 저널 OA 9.3% 2024: 0/1 OA 2025: 0/16 OA 2026: 4/26 OA 2024~2026 2026 Vol.7(4) p. 101032 Interstitial Lung Diseases and Idiop
Retraction 확인
출처
PubMed DOI OpenAlex 마지막 보강 2026-04-30

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: COPD exhibit superior anti-PD-1 responses through a distinctive immunological mechanism
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
COPD-driven epithelial remodeling expands CXCL14+ basal-like tumor cells, which orchestrate CXCL9+ macrophage recruitment via CXCL14-CXCR4 signaling, amplifying cytotoxic T cell infiltration. This COPD-associated tumor-macrophage axis predicts pathological response and represents both a promising biomarker and potential therapeutic target for refining immunotherapy strategies.
OpenAlex 토픽 · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Chronic Obstructive Pulmonary Disease (COPD) Research Cancer Immunotherapy and Biomarkers

Wang H, Jiang T

📝 환자 설명용 한 줄

Chen et al.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Haowei Wang, Tao Jiang (2026). Chronic obstructive pulmonary disease as a double-edged sword-reshaping NSCLC immunotherapy paradigms.. Med (New York, N.Y.), 7(4), 101032. https://doi.org/10.1016/j.medj.2026.101032
MLA Haowei Wang, et al.. "Chronic obstructive pulmonary disease as a double-edged sword-reshaping NSCLC immunotherapy paradigms.." Med (New York, N.Y.), vol. 7, no. 4, 2026, pp. 101032.
PMID 41966713 ↗

Abstract

Chen et al. demonstrate that NSCLC patients with COPD exhibit superior anti-PD-1 responses through a distinctive immunological mechanism. COPD-driven epithelial remodeling expands CXCL14+ basal-like tumor cells, which orchestrate CXCL9+ macrophage recruitment via CXCL14-CXCR4 signaling, amplifying cytotoxic T cell infiltration. This COPD-associated tumor-macrophage axis predicts pathological response and represents both a promising biomarker and potential therapeutic target for refining immunotherapy strategies.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반